Guizhou Bai Ling Enterprise Group Pharmaceutical Co., Ltd. 2025 Annual Independent Director's Performance Report
As an independent director of Guizhou Bai Ling Enterprise Group Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company"), I have strictly fulfilled my duties with integrity, diligence, and independence in accordance with the requirements of relevant laws, administrative regulations, normative documents such as the "Company Law of the People's Republic of China," "Securities Law of the People's Republic of China," "Management Measures for Independent Directors of Listed Companies," and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 1 - Standardized Operation of Main Board Listed Companies," as well as the "Articles of Association" and the "Independent Director Work System" of the Company. I have effectively exercised the role of an independent director, safeguarding the legitimate rights and interests of the Company and all shareholders. The situation of my performance of duties in 2025 is hereby reported as follows:
I. Basic Information of the Independent Director
I am Yan Guowen, female, born in October 1971, a Chinese national with no permanent overseas residency. I am a member of the Communist Party of China, holding a Ph.D. and an associate professor of accounting. I obtained my Master's and Ph.D. degrees from Chongqing University in 1998 and 2010, respectively. From July 1992 to September 1995, I was a cadre in the Yuzhong Branch of the Chongqing Municipal Real Estate Administration Bureau. From July 1998 to the present, I have been a lecturer, associate professor, and master's supervisor in the Accounting Department of the School of Economics and Business Administration, Chongqing University, primarily engaged in teaching and research in accounting, auditing, capital markets, and corporate finance. I have served as an independent director of the Company since December 11, 2023.